(19)

(11)

EP 4 440 509 A1

(12)

(43) Date of publication: 09.10.2024 Bulletin 2024/41 (21) Application number: 22840467.9 (22) Date of filing: 29.11.2022

(51) International Patent Classification (IPC):  A61F 2/958(2013.01) A61M 25/10(2013.01) A61F 2/24(2006.01) (52) Cooperative Patent Classification (CPC): A61F 2/2433; A61F 2250/0039; A61F 2210/0076; A61M 2025/1084; A61M 2025/1075; A61M 25/10184; A61M 2025/1093 (86) International application number: PCT/US2022/051159 (87) International publication number: WO 2023/101929 (08.06.2023 Gazette 2023/23)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 30.11.2021 US 202163264702 P (71) Applicant: Edwards Lifesciences Corporation Irvine, CA 92614 (US)	(72) Inventors: ZHU, Yidong, M. Irvine, CA 92614 (US) BULMAN, Erik Irvine, CA 92614 (US) (74) Representative: Eisenführ Speiser  Patentanwälte Rechtsanwälte PartGmbB Gollierstraße 4 80339 München 80339 München (DE)